Remove Accountability Remove Biotechnology Remove Medical Technology Remove Regulations
article thumbnail

Protecting the Consumer at the Heart of DTC Precision Medicine

Bill Of Health

The HIPAA Problem The privatization of next-generation medical technologies, especially in regenerative and precision medicine, further muddies the data-protection waters. The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so.

article thumbnail

From Regulation to Innovation: The Impact of the EU AI Act on XR and AI in Healthcare

Bill Of Health

This includes addressing potential specific AI-related risks—such as biases, discrimination, and data poisoning—as well as ensuring data security and privacy, and delineating liability for failures or harm caused by these technologies. These reforms streamline liability claims and establish clearer accountability for AI-generated issues.